Healive

Beijing Healive Science & Technology is a prominent Chinese biopharmaceutical company focused on the development and production of human vaccines. A core subsidiary of Sinovac Biotech, the company gained international recognition for developing Healive, the first Chinese-made inactivated Hepatitis A vaccine. Its product portfolio has expanded to include vaccines for Hepatitis B, seasonal influenza, and Hand, Foot, and Mouth Disease caused by Enterovirus 71. The company maintains large-scale manufacturing capabilities that meet high quality standards, enabling it to supply vaccines to both the Chinese national immunization program and international markets.